Showing results (191-200 of 410) with videos related to

Sort By:
Pageof 41
Journal of Biological Response Modifiers|October 1, 1990
Stimulation of granulopoiesis in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor: assessment of two routes of administrationF Herrmann, A Ganser, A Lindemann, et al.
Leukemia & Lymphoma|May 16, 2000
Defective megakaryocytic development in myelodysplastic syndromesW K Hofmann, U Kalina, S Koschmieder, et al.
Medical and Pediatric Oncology. Supplement|January 1, 1992
Interleukin-3 and granulocyte-macrophage colony-stimulating factor in combination: clinical implicationJ Frisch, A Ganser, D Hoelzer, et al.
Infection|November 1, 1995
A randomized study of imipenem compared to cefotaxime plus piperacillin as initial therapy of infections in granulocytopenic patientsA Böhme, G Just-Nübling, L Bergmann, et al.
Blood|February 1, 1985
Improved treatment results in childhood acute myelogenous leukemia: a report of the German cooperative study AML-BFM-78U Creutzig, J Ritter, H Riehm, et al.
Klinische Padiatrie|May 1, 1986
[Current results of cooperative AML therapy studies in children: BFM-78 and 83]U Creutzig, J Ritter, M Budde, et al.
Klinische Padiatrie|July 1, 1992
[Comparison of chemotherapy alone with allogeneic bone marrow transplantation in first full remission in children with acute myeloid leukemia in the AML-BFM-83 and AML-BFM-87 studies--matched pair analysis]U Creutzig, C Bender-Götze, T Klingebiel, et al.
Molecular and Cellular Biology|June 22, 1999
PIC-1/SUMO-1-modified PML-retinoic acid receptor alpha mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemiaT Sternsdorf, E Puccetti, K Jensen, et al.
Clinical and Experimental Rheumatology|January 2, 2003
Interleukin-10 expression: is there a neglected contribution of CD8+ T cells in rheumatoid arthritis joints?B Möller, T T Nguyen, U Kessler, et al.
Bone Marrow Transplantation|May 16, 2003
Peracute onset of severe tumor lysis syndrome immediately after 4 Gy fractionated TBI as part of reduced intensity preparative regimen in a patient with T-ALL with high tumor burdenD Linck, N Basara, V Tran, et al.
Pageof 41